Adicet Bio, Inc. (ACET): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:04 ET
- Event date
- 2026-11-11
- Accession no.
- 0001720580-26-000069
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Adicet Bio discloses Andrew Sinclair’s board resignation and committee appointments
Andrew Sinclair resigned from Adicet Bio’s Board and its Audit and Nominating and Corporate Governance Committees, effective November 13, 2026. The Board size will be reduced from seven to six. Current director Michael Grissinger was appointed to the Audit Committee and as chairperson of the Nominating and Corporate Governance Committee.
- Andrew Sinclair resigned from the Board and its Audit and NCG Committees, effective November 13, 2026.
- The Board size will be reduced from seven to six upon Sinclair’s resignation.
- Michael Grissinger was appointed to the Audit Committee and as NCG Committee chairperson on November 13, 2026.
- Sinclair’s resignation was not the result of any disagreement with management or the Board.
board changegovernance
Items reported
- Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | acet-20261111.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.